This HTML5 document contains 51 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
dctermshttp://purl.org/dc/terms/
n13http://localhost/temp/predkladatel/
n16http://linked.opendata.cz/resource/domain/vavai/projekt/
n7http://linked.opendata.cz/resource/domain/vavai/riv/tvurce/
n15http://linked.opendata.cz/ontology/domain/vavai/
shttp://schema.org/
n4http://linked.opendata.cz/ontology/domain/vavai/riv/
skoshttp://www.w3.org/2004/02/skos/core#
n2http://linked.opendata.cz/resource/domain/vavai/vysledek/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n5http://linked.opendata.cz/ontology/domain/vavai/riv/klicoveSlovo/
n12http://linked.opendata.cz/ontology/domain/vavai/riv/duvernostUdaju/
xsdhhttp://www.w3.org/2001/XMLSchema#
n17http://linked.opendata.cz/ontology/domain/vavai/riv/jazykVysledku/
n14http://linked.opendata.cz/ontology/domain/vavai/riv/aktivita/
n10http://linked.opendata.cz/ontology/domain/vavai/riv/obor/
n18http://linked.opendata.cz/ontology/domain/vavai/riv/druhVysledku/
n6http://linked.opendata.cz/resource/domain/vavai/vysledek/RIV%2F00216208%3A11110%2F05%3A00008669%21RIV06-MZ0-11110___/
n9http://reference.data.gov.uk/id/gregorian-year/

Statements

Subject Item
n2:RIV%2F00216208%3A11110%2F05%3A00008669%21RIV06-MZ0-11110___
rdf:type
n15:Vysledek skos:Concept
dcterms:description
Rosiglitazone, homocysteine, creatinine Rosiglitazon, homocystein, kreatinin Rosiglitazone, homocysteine, creatinine
dcterms:title
Effect of rosiglitazone on homocysteine and creatinine levels in patients with type 2 diabetes Effect of rosiglitazone on homocysteine and creatinine levels in patients with type 2 diabetes Vliv rosiglitazonu na hladinu homocysteinu a kreatininu u pacientů s diabetem 2. typu
skos:prefLabel
Vliv rosiglitazonu na hladinu homocysteinu a kreatininu u pacientů s diabetem 2. typu Effect of rosiglitazone on homocysteine and creatinine levels in patients with type 2 diabetes Effect of rosiglitazone on homocysteine and creatinine levels in patients with type 2 diabetes
skos:notation
RIV/00216208:11110/05:00008669!RIV06-MZ0-11110___
n4:strany
367;368
n4:aktivita
n14:P
n4:aktivity
P(NB7392)
n4:cisloPeriodika
1
n4:dodaniDat
n9:2006
n4:domaciTvurceVysledku
n7:9909443 n7:2878763 n7:9950702 n7:3336050
n4:druhVysledku
n18:J
n4:duvernostUdaju
n12:S
n4:entitaPredkladatele
n6:predkladatel
n4:idSjednocenehoVysledku
519416
n4:idVysledku
RIV/00216208:11110/05:00008669
n4:jazykVysledku
n17:eng
n4:klicovaSlova
Effect; rosiglitazone; homocysteine; creatinine; levels; patients; diabetes
n4:klicoveSlovo
n5:creatinine n5:levels n5:rosiglitazone n5:homocysteine n5:diabetes n5:Effect n5:patients
n4:kodStatuVydavatele
GB - Spojené království Velké Británie a Severního Irska
n4:kontrolniKodProRIV
[12B28CFC7B78]
n4:nazevZdroje
Atherosclerosis
n4:obor
n10:FB
n4:pocetDomacichTvurcuVysledku
4
n4:pocetTvurcuVysledku
5
n4:projekt
n16:NB7392
n4:rokUplatneniVysledku
n9:2005
n4:svazekPeriodika
183
n4:tvurceVysledku
Kasalová, Zdislava Češka, Richard Krejčí, Hana Štulc, Tomáš
s:issn
0021-9150
s:numberOfPages
2
n13:organizacniJednotka
11110